Who founded Arkstone?

Arkstone was founded by Dave Gross, Dr. Ari Frenkel, Sol Levi in 2018.

Who are Arkstone's investors?

Arkstone's investors include ARCHIMED Japan.

Arkstone

Founded 2018 · 43 employees on LinkedIn · 1 known investors

Find your way into Arkstone

269 people in our graph share verified history with the Arkstone team — schools, employers, funds. One of them is your warm intro.

Ben Yuunlockedknows Ian Campbell · together at NextInput (overlapped)

knows the team · via Arkstone

knows the team · via NextInput

×3knows the team · via OnScale

×5knows the team · via Ansys

knows the team · via IDT

Arkstone develops AI-powered clinical decision support tools to guide healthcare providers in appropriate antibiotic prescribing and antimicrobial stewardship, reducing unnecessary antibiotic use and antimicrobial resistance. The company serves laboratory professionals, infectious disease specialists, and healthcare systems worldwide.

AI & Machine Learning Digital Health Healthtech Medical Devices

Founders & leadership

Arkstone was founded in 2018 by Dave Gross, Dr. Ari Frenkel, and Sol Levi.

Dave Gross Co-Founder, Chief Technology OfficerDave Gross is an attorney and software executive who previously founded Empower NY, a property management compliance platform acquired by DMGT in 2015, and has held senior technology and operations roles at Fortune 1000 and startup companies. He holds a JD from Cardozo School of Law and a BA from Queens College.

Dr. Ari FrenkelCo-Founder, Chief Science Officer

Sol Levi Co-Founder, Chief Customer OfficerCo-founder and Chief Customer Officer of Arkstone, which develops AI-powered clinical decision support tools for appropriate antibiotic prescribing and antimicrobial stewardship.

Ian Campbell CEO and Executive ChairmanIan Campbell holds a master's degree in aerospace engineering from Georgia Tech and has previously founded two venture-backed technology companies—NextInput (acquired by Qorvo) and OnScale (acquired by Ansys)—focused on advanced hardware and simulation platforms. He is currently CEO and Executive Chairman of Arkstone, which develops AI-powered clinical decision support tools for antimicrobial stewardship.

Investors · 1

ARCHIMED Japanlisted by ARCHIMED JapanLyon · $10.8M – $1.1B

Frequently asked questions

What does Arkstone do?: Arkstone develops AI-powered clinical decision support tools to guide healthcare providers in appropriate antibiotic prescribing and antimicrobial stewardship, reducing unnecessary antibiotic use and antimicrobial resistance. The company serves laboratory professionals, infectious disease specialists, and healthcare systems worldwide.
Who founded Arkstone?: Arkstone was founded by Dave Gross, Dr. Ari Frenkel, Sol Levi in 2018.
Who are Arkstone's investors?: Arkstone's investors include ARCHIMED Japan.